Found: 6
Select item for more details and to access through your institution.
WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 7, p. 2877, doi. 10.1172/JCI70156
- By:
- Publication type:
- Article
Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed‐CD19 selective pressure.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 333, doi. 10.1111/bjh.15812
- By:
- Publication type:
- Article
Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4921, doi. 10.3390/cancers14194921
- By:
- Publication type:
- Article
Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2020, v. 6, n. 4, p. 1, doi. 10.1101/mcs.a005439
- By:
- Publication type:
- Article
Wnt/β-Catenin Signaling and AXIN1 Regulate Apoptosis Triggered by Inhibition of the Mutant Kinase BRAF<sup>V600E</sup> in Human Melanoma.
- Published in:
- Science Signaling, 2012, v. 5, n. 206, p. 1, doi. 10.1126/scisignal.2002274
- By:
- Publication type:
- Article
The V-ATPase B1-subunit promoter drives expression of Cre recombinase in intercalated cells of the kidney.
- Published in:
- Kidney International, 2009, v. 75, n. 4, p. 435, doi. 10.1038/ki.2008.569
- By:
- Publication type:
- Article